PeptideDB

GRK2i

CAS No.: 148505-03-7

GRK2i is a GRK2 inhibitory polypeptide that specifically inhibits Gβγ activation of GRK2. GRK2i corresponds to the Gβ
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

CAS 148505-03-7
Sequence H-Trp-Lys-Lys-Glu-Leu-Arg-Asp-Ala-Tyr-Arg-Glu-Ala-Gln-Gln-Leu-Val-Gln-Arg-Val-Pro-Lys-Met-Lys-Asn-Lys-Pro-Arg-Ser-OH
Sequence Single WKKELRDAYREAQQLVQRVPKMKNKPRS
Molecular Formula C153H256N50O41S
Molecular Weight 3484.08
Technology Synthetic
Storage -20°C, avoid light, cool and dry place
Description GRK2i is a GRK2 inhibitory polypeptide that specifically inhibits Gβγ activation of GRK2. GRK2i corresponds to the Gβγ-binding domain and acts as a cellular Gβγ antagonist.
References 1.  Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates Gβγ-mediated signaling. Koch et al (1994). J.Biol.Chem. 269 6193 PMID: 8119963 2.  A βγ dimer derived from G13 transduces the angiotensin AT1 receptor signal to stimulation of Ca2+ channels in rat portal vein myocytes. Macrez et al (1997). J.Biol.Chem. 272 23180 PMID: 9287322 3.  Two distinct mechanisms mediate acute μ-opioid receptor desensitization in native neurons. Dang et al (2009). J.Neurosci. 29 3322 PMID: 19279269 4.  Nerve growth factor induces neurite outgrowth of PC12 cells by promoting Gβγ-microtubule interaction. Jorge A Sierra-Fonseca, et al. BMC Neurosci. 2014 Dec 31;15:132.